Rank | Gene Set | Z-score |
---|---|---|
1 | interferon-gamma production (GO:0032609) | 7.02288466 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.49516389 |
3 | leukocyte aggregation (GO:0070486) | 6.20418878 |
4 | negative regulation of cell killing (GO:0031342) | 6.19988044 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.19988044 |
6 | T cell migration (GO:0072678) | 5.75793422 |
7 | cellular response to interleukin-15 (GO:0071350) | 5.31528996 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.20382034 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.20382034 |
10 | modulation by symbiont of host immune response (GO:0052553) | 5.20382034 |
11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.20382034 |
12 | modulation by symbiont of host defense response (GO:0052031) | 5.20382034 |
13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.20382034 |
14 | negative T cell selection (GO:0043383) | 5.20360511 |
15 | response to interleukin-15 (GO:0070672) | 5.14757942 |
16 | negative thymic T cell selection (GO:0045060) | 5.10833273 |
17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03994521 |
18 | activated T cell proliferation (GO:0050798) | 4.94551315 |
19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.77856637 |
20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.76392009 |
21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.73263718 |
22 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.68035375 |
23 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.68035375 |
24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.59791455 |
25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.59791455 |
26 | regulation of gamma-delta T cell activation (GO:0046643) | 4.52489050 |
27 | detection of other organism (GO:0098543) | 4.47058163 |
28 | positive thymic T cell selection (GO:0045059) | 4.45291654 |
29 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.38609752 |
30 | leukocyte cell-cell adhesion (GO:0007159) | 4.35080979 |
31 | macrophage activation involved in immune response (GO:0002281) | 4.34951814 |
32 | cellular extravasation (GO:0045123) | 4.30952041 |
33 | detection of molecule of bacterial origin (GO:0032490) | 4.27807048 |
34 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.25171446 |
35 | cellular defense response (GO:0006968) | 4.15824905 |
36 | detection of bacterium (GO:0016045) | 4.12410016 |
37 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.11530167 |
38 | regulation of B cell differentiation (GO:0045577) | 4.08911484 |
39 | negative regulation of interleukin-12 production (GO:0032695) | 4.07237180 |
40 | detection of external biotic stimulus (GO:0098581) | 4.03086691 |
41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.01442629 |
42 | natural killer cell activation (GO:0030101) | 3.98757448 |
43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.98684349 |
44 | positive regulation of isotype switching (GO:0045830) | 3.97935515 |
45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.95391578 |
46 | thymic T cell selection (GO:0045061) | 3.94569310 |
47 | response to peptidoglycan (GO:0032494) | 3.94278920 |
48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.90326311 |
49 | positive T cell selection (GO:0043368) | 3.90156577 |
50 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.86224123 |
51 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.86224123 |
52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.85714110 |
53 | response to host immune response (GO:0052572) | 3.82854451 |
54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82854451 |
55 | microglial cell activation (GO:0001774) | 3.81464890 |
56 | neutrophil activation (GO:0042119) | 3.78466604 |
57 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.76421418 |
58 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.76421418 |
59 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.75526082 |
60 | cellular response to type I interferon (GO:0071357) | 3.68811909 |
61 | type I interferon signaling pathway (GO:0060337) | 3.68811909 |
62 | response to type I interferon (GO:0034340) | 3.65924364 |
63 | dendritic cell chemotaxis (GO:0002407) | 3.63600694 |
64 | respiratory burst (GO:0045730) | 3.58686659 |
65 | neutrophil mediated immunity (GO:0002446) | 3.57729117 |
66 | regulation of cell killing (GO:0031341) | 3.55504361 |
67 | detection of biotic stimulus (GO:0009595) | 3.53570024 |
68 | T cell selection (GO:0045058) | 3.52578341 |
69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52559970 |
70 | positive regulation of DNA recombination (GO:0045911) | 3.50816013 |
71 | lymphocyte migration (GO:0072676) | 3.50400007 |
72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.50192701 |
73 | response to host (GO:0075136) | 3.50192701 |
74 | response to host defenses (GO:0052200) | 3.50192701 |
75 | myeloid cell activation involved in immune response (GO:0002275) | 3.49274235 |
76 | dendritic cell migration (GO:0036336) | 3.47390728 |
77 | mast cell activation (GO:0045576) | 3.47296480 |
78 | germinal center formation (GO:0002467) | 3.46755027 |
79 | granulocyte activation (GO:0036230) | 3.43736727 |
80 | positive regulation of B cell mediated immunity (GO:0002714) | 3.42720802 |
81 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.42720802 |
82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.42472111 |
83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42064630 |
84 | regulation of T cell chemotaxis (GO:0010819) | 3.41638850 |
85 | positive regulation of T cell chemotaxis (GO:0010820) | 3.41638850 |
86 | heterotypic cell-cell adhesion (GO:0034113) | 3.40850830 |
87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40184540 |
88 | macrophage activation (GO:0042116) | 3.38727942 |
89 | tolerance induction (GO:0002507) | 3.36762896 |
90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.35628321 |
91 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.34020449 |
92 | response to muramyl dipeptide (GO:0032495) | 3.30358344 |
93 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.24928622 |
94 | immunoglobulin mediated immune response (GO:0016064) | 3.22066298 |
95 | leukocyte degranulation (GO:0043299) | 3.20516020 |
96 | T cell proliferation (GO:0042098) | 3.20030002 |
97 | myeloid leukocyte mediated immunity (GO:0002444) | 3.19166555 |
98 | positive regulation of cell killing (GO:0031343) | 3.17222571 |
99 | leukocyte tethering or rolling (GO:0050901) | 3.16861898 |
100 | T cell activation involved in immune response (GO:0002286) | 3.16509201 |
101 | T cell receptor signaling pathway (GO:0050852) | 3.16392829 |
102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16184460 |
103 | regulation of activation of Janus kinase activity (GO:0010533) | 3.15388944 |
104 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.14074139 |
105 | neutrophil activation involved in immune response (GO:0002283) | 3.13978884 |
106 | megakaryocyte development (GO:0035855) | 3.13848780 |
107 | T cell costimulation (GO:0031295) | 3.13645053 |
108 | B cell receptor signaling pathway (GO:0050853) | 3.13111008 |
109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12857175 |
110 | T-helper cell differentiation (GO:0042093) | 3.12135463 |
111 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.12135463 |
112 | T cell homeostasis (GO:0043029) | 3.10674775 |
113 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10397008 |
114 | defense response to protozoan (GO:0042832) | 3.10156331 |
115 | alpha-beta T cell activation (GO:0046631) | 3.10114262 |
116 | lymphocyte costimulation (GO:0031294) | 3.09507844 |
117 | negative regulation of adaptive immune response (GO:0002820) | 3.07264719 |
118 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.07187091 |
119 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07150010 |
120 | myeloid dendritic cell activation (GO:0001773) | 3.06916073 |
121 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05999951 |
122 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.05794732 |
123 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.05794732 |
124 | T cell differentiation involved in immune response (GO:0002292) | 3.05794732 |
125 | negative regulation of phagocytosis (GO:0050765) | 3.04451071 |
126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04380202 |
127 | regulation of response to interferon-gamma (GO:0060330) | 3.03887994 |
128 | regulation of isotype switching (GO:0045191) | 3.02392977 |
129 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.01655128 |
130 | positive regulation of macrophage differentiation (GO:0045651) | 3.00988624 |
131 | positive regulation of immunoglobulin production (GO:0002639) | 2.99826505 |
132 | response to protozoan (GO:0001562) | 2.99274768 |
133 | negative regulation of type 2 immune response (GO:0002829) | 2.99183255 |
134 | negative regulation of innate immune response (GO:0045824) | 2.99174576 |
135 | regulation of mast cell degranulation (GO:0043304) | 2.98646308 |
136 | regulation of tolerance induction (GO:0002643) | 2.97934021 |
137 | regulation of T cell tolerance induction (GO:0002664) | 2.97871683 |
138 | response to interferon-alpha (GO:0035455) | 2.97311018 |
139 | positive regulation of B cell differentiation (GO:0045579) | 2.96823200 |
140 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.95847569 |
141 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95620214 |
142 | positive regulation of interferon-gamma production (GO:0032729) | 2.94624619 |
143 | regulation of B cell mediated immunity (GO:0002712) | 2.94134766 |
144 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.93559844 |
145 | positive regulation of interferon-alpha production (GO:0032727) | 2.93558691 |
146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92897992 |
147 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.92535995 |
148 | mast cell activation involved in immune response (GO:0002279) | 2.92399531 |
149 | mast cell degranulation (GO:0043303) | 2.92399531 |
150 | hepatocyte apoptotic process (GO:0097284) | 2.91924581 |
151 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91903629 |
152 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91483167 |
153 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90245825 |
154 | T cell differentiation (GO:0030217) | 2.88539262 |
155 | alpha-beta T cell differentiation (GO:0046632) | 2.88194673 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.77126782 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.63235743 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.48330948 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00284850 |
5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87889279 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86019358 |
7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.78601471 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73815254 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.47782324 |
10 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.39141396 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.34828597 |
12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.07145450 |
13 | MYB_26560356_Chip-Seq_TH2_Human | 3.04334351 |
14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.93907007 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92430378 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87969961 |
17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83392518 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.78638316 |
19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71096673 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71030468 |
21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.69923491 |
22 | MYB_26560356_Chip-Seq_TH1_Human | 2.61611972 |
23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55794246 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.54779185 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 2.48404441 |
26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.41472111 |
27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39671450 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22621883 |
29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18763665 |
30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.16521677 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16002962 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12737786 |
33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08862487 |
34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99724663 |
35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96710844 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.95599437 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83455450 |
38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81070564 |
39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.80108771 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78138861 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75307943 |
42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69423785 |
43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.66627050 |
44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62972278 |
45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62411051 |
46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62046223 |
47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60845214 |
48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59088052 |
49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54470948 |
50 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.53385817 |
51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53177838 |
52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53028953 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52211485 |
54 | MAF_26560356_Chip-Seq_TH2_Human | 1.48759685 |
55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47566828 |
56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45015272 |
57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44056651 |
58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41170003 |
59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37388762 |
60 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.36122099 |
61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33019708 |
62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28255337 |
63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25627064 |
64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24493858 |
65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21076119 |
66 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17216721 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16837016 |
68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15981714 |
69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14777091 |
70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12400933 |
71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11343766 |
72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09187053 |
73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07858114 |
74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06691122 |
75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04819918 |
76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03543304 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02375204 |
78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01983142 |
79 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96265981 |
80 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94032194 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93298918 |
82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91594110 |
83 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91318026 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91160618 |
85 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90335721 |
86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90104286 |
87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86308624 |
88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86039251 |
89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86016847 |
90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85928818 |
91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85656915 |
92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84442465 |
93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84208013 |
94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.83357279 |
95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81382522 |
96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81140979 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81050507 |
98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80067884 |
99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.79687766 |
100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79299599 |
101 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79039174 |
102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77945182 |
103 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77783783 |
104 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76605273 |
105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76268653 |
106 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.75358015 |
107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75077334 |
108 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74661882 |
109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.74436500 |
110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74312637 |
111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74248808 |
112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74035436 |
113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73019708 |
114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72266086 |
115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72002634 |
116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69767931 |
117 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69703894 |
118 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.64415406 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 4.72104568 |
2 | MP0009785_altered_susceptibility_to | 3.68024556 |
3 | MP0001835_abnormal_antigen_presentation | 3.58946049 |
4 | MP0003763_abnormal_thymus_physiology | 3.36812911 |
5 | MP0003436_decreased_susceptibility_to | 3.12723548 |
6 | MP0006082_CNS_inflammation | 3.12207545 |
7 | MP0000685_abnormal_immune_system | 3.10292054 |
8 | MP0001800_abnormal_humoral_immune | 3.09987535 |
9 | MP0005025_abnormal_response_to | 2.92926080 |
10 | * MP0002420_abnormal_adaptive_immunity | 2.88593117 |
11 | MP0005000_abnormal_immune_tolerance | 2.88557782 |
12 | MP0002396_abnormal_hematopoietic_system | 2.86553994 |
13 | * MP0001819_abnormal_immune_cell | 2.86136799 |
14 | * MP0002723_abnormal_immune_serum | 2.80204879 |
15 | MP0005387_immune_system_phenotype | 2.72503566 |
16 | MP0001790_abnormal_immune_system | 2.72503566 |
17 | MP0002452_abnormal_antigen_presenting | 2.70321519 |
18 | MP0002398_abnormal_bone_marrow | 2.63113673 |
19 | MP0002419_abnormal_innate_immunity | 2.58714147 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.54318388 |
21 | MP0005464_abnormal_platelet_physiology | 2.35112843 |
22 | MP0002405_respiratory_system_inflammati | 2.34372164 |
23 | MP0000716_abnormal_immune_system | 2.32852650 |
24 | MP0003724_increased_susceptibility_to | 2.22595782 |
25 | MP0001873_stomach_inflammation | 2.21386313 |
26 | MP0009333_abnormal_splenocyte_physiolog | 2.21086903 |
27 | MP0000858_altered_metastatic_potential | 2.11645630 |
28 | MP0010155_abnormal_intestine_physiology | 2.10303546 |
29 | MP0002006_tumorigenesis | 2.09233460 |
30 | MP0002722_abnormal_immune_system | 2.09042271 |
31 | MP0003448_altered_tumor_morphology | 2.06666115 |
32 | MP0002166_altered_tumor_susceptibility | 2.05674058 |
33 | MP0004808_abnormal_hematopoietic_stem | 2.00169779 |
34 | MP0000689_abnormal_spleen_morphology | 1.99709032 |
35 | MP0000703_abnormal_thymus_morphology | 1.96761338 |
36 | MP0002429_abnormal_blood_cell | 1.94458440 |
37 | MP0001845_abnormal_inflammatory_respons | 1.88102911 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.82386392 |
39 | MP0001545_abnormal_hematopoietic_system | 1.82386392 |
40 | MP0009278_abnormal_bone_marrow | 1.80556964 |
41 | MP0002933_joint_inflammation | 1.80168570 |
42 | MP0002132_abnormal_respiratory_system | 1.74991982 |
43 | MP0004947_skin_inflammation | 1.73131464 |
44 | MP0001853_heart_inflammation | 1.71745914 |
45 | MP0003300_gastrointestinal_ulcer | 1.67368581 |
46 | MP0008260_abnormal_autophagy | 1.66968305 |
47 | MP0003303_peritoneal_inflammation | 1.62664598 |
48 | MP0003866_abnormal_defecation | 1.60199770 |
49 | MP0003191_abnormal_cellular_cholesterol | 1.54268214 |
50 | MP0000490_abnormal_crypts_of | 1.54168869 |
51 | MP0001533_abnormal_skeleton_physiology | 1.52896161 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.51622185 |
53 | MP0005174_abnormal_tail_pigmentation | 1.40435687 |
54 | MP0008469_abnormal_protein_level | 1.36273036 |
55 | MP0004883_abnormal_blood_vessel | 1.29033493 |
56 | MP0010307_abnormal_tumor_latency | 1.27581161 |
57 | MP0003183_abnormal_peptide_metabolism | 1.23590899 |
58 | MP0005451_abnormal_body_composition | 1.22613057 |
59 | MP0002019_abnormal_tumor_incidence | 1.15647018 |
60 | MP0000343_altered_response_to | 1.15626957 |
61 | MP0005310_abnormal_salivary_gland | 1.11839165 |
62 | MP0001851_eye_inflammation | 1.11277960 |
63 | MP0000569_abnormal_digit_pigmentation | 1.06815862 |
64 | MP0009764_decreased_sensitivity_to | 1.04520361 |
65 | MP0003075_altered_response_to | 1.03428387 |
66 | MP0003690_abnormal_glial_cell | 1.03199099 |
67 | MP0005164_abnormal_response_to | 1.00693846 |
68 | MP0000015_abnormal_ear_pigmentation | 0.93867520 |
69 | MP0010352_gastrointestinal_tract_polyps | 0.93454784 |
70 | MP0002998_abnormal_bone_remodeling | 0.92151721 |
71 | MP0003172_abnormal_lysosome_physiology | 0.91261763 |
72 | MP0009763_increased_sensitivity_to | 0.87826875 |
73 | MP0005075_abnormal_melanosome_morpholog | 0.83425635 |
74 | MP0003566_abnormal_cell_adhesion | 0.83372375 |
75 | MP0004510_myositis | 0.82760183 |
76 | MP0002009_preneoplasia | 0.80824404 |
77 | MP0002095_abnormal_skin_pigmentation | 0.80473088 |
78 | MP0003656_abnormal_erythrocyte_physiolo | 0.80335619 |
79 | MP0005166_decreased_susceptibility_to | 0.80006395 |
80 | MP0008007_abnormal_cellular_replicative | 0.76989520 |
81 | MP0000604_amyloidosis | 0.74779227 |
82 | MP0003693_abnormal_embryo_hatching | 0.72917348 |
83 | MP0005023_abnormal_wound_healing | 0.72315295 |
84 | MP0004130_abnormal_muscle_cell | 0.71767604 |
85 | MP0002277_abnormal_respiratory_mucosa | 0.69616265 |
86 | MP0003045_fibrosis | 0.69297645 |
87 | MP0005390_skeleton_phenotype | 0.68698557 |
88 | MP0004484_altered_response_of | 0.63916687 |
89 | MP0002138_abnormal_hepatobiliary_system | 0.63886819 |
90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62151363 |
91 | MP0003795_abnormal_bone_structure | 0.61716841 |
92 | MP0003077_abnormal_cell_cycle | 0.60781568 |
93 | MP0003943_abnormal_hepatobiliary_system | 0.60753533 |
94 | MP0002877_abnormal_melanocyte_morpholog | 0.60335120 |
95 | MP0010094_abnormal_chromosome_stability | 0.59951760 |
96 | MP0002332_abnormal_exercise_endurance | 0.58084384 |
97 | MP0008057_abnormal_DNA_replication | 0.57753640 |
98 | MP0002693_abnormal_pancreas_physiology | 0.53945834 |
99 | MP0008874_decreased_physiological_sensi | 0.53352689 |
100 | MP0001191_abnormal_skin_condition | 0.52669428 |
101 | MP0000371_diluted_coat_color | 0.51856521 |
102 | MP0001663_abnormal_digestive_system | 0.51728444 |
103 | MP0003828_pulmonary_edema | 0.51309720 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.51101967 |
105 | MP0005076_abnormal_cell_differentiation | 0.50948365 |
106 | MP0005319_abnormal_enzyme/_coenzyme | 0.50869193 |
107 | MP0001986_abnormal_taste_sensitivity | 0.50099361 |
108 | MP0003091_abnormal_cell_migration | 0.49736970 |
109 | MP0000249_abnormal_blood_vessel | 0.49399126 |
110 | MP0008058_abnormal_DNA_repair | 0.48905418 |
111 | MP0000477_abnormal_intestine_morphology | 0.48889285 |
112 | MP0003453_abnormal_keratinocyte_physiol | 0.48749252 |
113 | MP0008873_increased_physiological_sensi | 0.48346173 |
114 | MP0003279_aneurysm | 0.48070181 |
115 | MP0000609_abnormal_liver_physiology | 0.47139359 |
116 | MP0001243_abnormal_dermal_layer | 0.46745554 |
117 | MP0008004_abnormal_stomach_pH | 0.45615988 |
118 | MP0004381_abnormal_hair_follicle | 0.45316631 |
119 | MP0004264_abnormal_extraembryonic_tissu | 0.44336547 |
120 | MP0005388_respiratory_system_phenotype | 0.43349437 |
121 | MP0002133_abnormal_respiratory_system | 0.43349437 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myositis (HP:0100614) | 6.19570643 |
2 | Optic neuritis (HP:0100653) | 5.55997723 |
3 | Retrobulbar optic neuritis (HP:0100654) | 5.55997723 |
4 | Orchitis (HP:0100796) | 5.21761101 |
5 | Recurrent abscess formation (HP:0002722) | 5.10405830 |
6 | Eczematoid dermatitis (HP:0000976) | 4.96689419 |
7 | T lymphocytopenia (HP:0005403) | 4.65380183 |
8 | Abnormality of T cell number (HP:0011839) | 4.58019819 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.28302743 |
10 | IgM deficiency (HP:0002850) | 4.24641283 |
11 | Recurrent fungal infections (HP:0002841) | 4.14387414 |
12 | Recurrent bacterial skin infections (HP:0005406) | 4.10045885 |
13 | Encephalitis (HP:0002383) | 4.04973337 |
14 | Meningitis (HP:0001287) | 3.91411079 |
15 | Nasal polyposis (HP:0100582) | 3.88449966 |
16 | Abnormality of T cells (HP:0002843) | 3.84706697 |
17 | Keratoconjunctivitis sicca (HP:0001097) | 3.82490266 |
18 | Abnormality of macrophages (HP:0004311) | 3.66955187 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.62532753 |
20 | Obstructive lung disease (HP:0006536) | 3.52696629 |
21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52696629 |
22 | Recurrent viral infections (HP:0004429) | 3.47807418 |
23 | Keratoconjunctivitis (HP:0001096) | 3.45652182 |
24 | Abnormality of the nasal mucosa (HP:0000433) | 3.43906347 |
25 | Prolonged bleeding time (HP:0003010) | 3.42364116 |
26 | Stomatitis (HP:0010280) | 3.40455658 |
27 | Mediastinal lymphadenopathy (HP:0100721) | 3.39285138 |
28 | Spontaneous hematomas (HP:0007420) | 3.37846232 |
29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.37185694 |
30 | Arterial thrombosis (HP:0004420) | 3.37019689 |
31 | Vasculitis (HP:0002633) | 3.29040705 |
32 | Chronic otitis media (HP:0000389) | 3.27197924 |
33 | Pustule (HP:0200039) | 3.25831117 |
34 | Hypochromic microcytic anemia (HP:0004840) | 3.24831569 |
35 | Abnormality of T cell physiology (HP:0011840) | 3.08035588 |
36 | Recurrent bronchitis (HP:0002837) | 3.07899131 |
37 | Episodic fever (HP:0001954) | 3.04504824 |
38 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.03000087 |
39 | Recurrent cutaneous fungal infections (HP:0011370) | 3.03000087 |
40 | Hypochromic anemia (HP:0001931) | 3.00128262 |
41 | Hemoptysis (HP:0002105) | 2.98771211 |
42 | Pulmonary infiltrates (HP:0002113) | 2.98483470 |
43 | Recurrent skin infections (HP:0001581) | 2.96532519 |
44 | Panhypogammaglobulinemia (HP:0003139) | 2.94840437 |
45 | Epistaxis (HP:0000421) | 2.87720997 |
46 | Joint swelling (HP:0001386) | 2.86623582 |
47 | Severe combined immunodeficiency (HP:0004430) | 2.86579832 |
48 | Thrombocytosis (HP:0001894) | 2.83583004 |
49 | Leukocytosis (HP:0001974) | 2.83218917 |
50 | Petechiae (HP:0000967) | 2.81411963 |
51 | Peritonitis (HP:0002586) | 2.80930137 |
52 | Thyroiditis (HP:0100646) | 2.75284746 |
53 | IgG deficiency (HP:0004315) | 2.72898303 |
54 | B lymphocytopenia (HP:0010976) | 2.71430099 |
55 | Abnormality of B cell number (HP:0010975) | 2.71430099 |
56 | Inflammation of the large intestine (HP:0002037) | 2.69932804 |
57 | Autoimmune thrombocytopenia (HP:0001973) | 2.69104205 |
58 | Increased IgE level (HP:0003212) | 2.68425176 |
59 | Combined immunodeficiency (HP:0005387) | 2.68155718 |
60 | Lymphopenia (HP:0001888) | 2.65992256 |
61 | Gingival bleeding (HP:0000225) | 2.62485148 |
62 | Eosinophilia (HP:0001880) | 2.62426799 |
63 | Gingivitis (HP:0000230) | 2.61808279 |
64 | Abnormality of eosinophils (HP:0001879) | 2.61727427 |
65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57499472 |
66 | Hypoproteinemia (HP:0003075) | 2.56154912 |
67 | Abnormality of the fingertips (HP:0001211) | 2.55978655 |
68 | Gastrointestinal inflammation (HP:0004386) | 2.54796470 |
69 | Pulmonary embolism (HP:0002204) | 2.52470763 |
70 | Periodontitis (HP:0000704) | 2.52103322 |
71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50453261 |
72 | Osteomyelitis (HP:0002754) | 2.43955090 |
73 | Lymphoma (HP:0002665) | 2.43015443 |
74 | Chronic diarrhea (HP:0002028) | 2.39441374 |
75 | Abnormal platelet volume (HP:0011876) | 2.38982002 |
76 | Abnormality of the prostate (HP:0008775) | 2.34809384 |
77 | Abnormal platelet function (HP:0011869) | 2.31507217 |
78 | Impaired platelet aggregation (HP:0003540) | 2.31507217 |
79 | Granulocytopenia (HP:0001913) | 2.29761797 |
80 | Keratitis (HP:0000491) | 2.28035108 |
81 | Cellulitis (HP:0100658) | 2.27612418 |
82 | Increased IgM level (HP:0003496) | 2.23802293 |
83 | Microcytic anemia (HP:0001935) | 2.21407310 |
84 | Chest pain (HP:0100749) | 2.20783788 |
85 | Glomerulopathy (HP:0100820) | 2.20095521 |
86 | Sepsis (HP:0100806) | 2.18637081 |
87 | Acute myeloid leukemia (HP:0004808) | 2.18247417 |
88 | Stomach cancer (HP:0012126) | 2.16650499 |
89 | Anorexia (HP:0002039) | 2.15315732 |
90 | Premature loss of primary teeth (HP:0006323) | 2.13203658 |
91 | Gangrene (HP:0100758) | 2.12925150 |
92 | Hypergammaglobulinemia (HP:0010702) | 2.11997715 |
93 | IgA deficiency (HP:0002720) | 2.07473813 |
94 | Abnormality of the peritoneum (HP:0002585) | 2.06548297 |
95 | Acne (HP:0001061) | 2.03877256 |
96 | Urticaria (HP:0001025) | 2.03422511 |
97 | Skin ulcer (HP:0200042) | 2.02006311 |
98 | Vertigo (HP:0002321) | 2.01473968 |
99 | Menorrhagia (HP:0000132) | 2.01362419 |
100 | Abnormality of the pleura (HP:0002103) | 2.00669757 |
101 | Subacute progressive viral hepatitis (HP:0006572) | 2.00247500 |
102 | Cheilitis (HP:0100825) | 2.00221305 |
103 | Autoimmune hemolytic anemia (HP:0001890) | 2.00095076 |
104 | Colitis (HP:0002583) | 1.99388347 |
105 | Myelodysplasia (HP:0002863) | 1.99099133 |
106 | Interstitial pulmonary disease (HP:0006530) | 1.98808792 |
107 | Gastrointestinal infarctions (HP:0005244) | 1.96467618 |
108 | Spinal cord lesions (HP:0100561) | 1.96027643 |
109 | Syringomyelia (HP:0003396) | 1.96027643 |
110 | Skin rash (HP:0000988) | 1.94421236 |
111 | Acute hepatic failure (HP:0006554) | 1.94207462 |
112 | Slow saccadic eye movements (HP:0000514) | 1.94030956 |
113 | Recurrent sinusitis (HP:0011108) | 1.93021880 |
114 | Hemiplegia (HP:0002301) | 1.92334359 |
115 | Polyneuropathy (HP:0001271) | 1.90162272 |
116 | Abnormality of the endocardium (HP:0004306) | 1.88945764 |
117 | Absent frontal sinuses (HP:0002688) | 1.88782796 |
118 | Hematochezia (HP:0002573) | 1.88502587 |
119 | Abnormality of the pericardium (HP:0001697) | 1.88388645 |
120 | Papilledema (HP:0001085) | 1.87753018 |
121 | Abnormality of iron homeostasis (HP:0011031) | 1.87411564 |
122 | Amaurosis fugax (HP:0100576) | 1.86479270 |
123 | Increased density of long bones (HP:0006392) | 1.85763169 |
124 | Viral hepatitis (HP:0006562) | 1.82672207 |
125 | Verrucae (HP:0200043) | 1.80593849 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 5.20469993 |
2 | MAP4K1 | 4.22052356 |
3 | ITK | 3.18914913 |
4 | JAK3 | 3.14220553 |
5 | TEC | 2.53480479 |
6 | BTK | 2.47263363 |
7 | IRAK4 | 2.46266953 |
8 | STK10 | 2.44338069 |
9 | ZAP70 | 2.32105231 |
10 | MAP3K14 | 2.30121190 |
11 | JAK1 | 2.28246008 |
12 | TYK2 | 2.04086104 |
13 | CSK | 2.02458111 |
14 | KIT | 1.88941746 |
15 | TBK1 | 1.79154035 |
16 | TGFBR2 | 1.76392279 |
17 | GRK6 | 1.73218384 |
18 | IKBKE | 1.70513820 |
19 | FES | 1.67718089 |
20 | ERN1 | 1.65263828 |
21 | LCK | 1.63615201 |
22 | PRPF4B | 1.62365901 |
23 | BLK | 1.55379636 |
24 | MATK | 1.50115318 |
25 | FLT3 | 1.50032636 |
26 | TAOK3 | 1.48059677 |
27 | SYK | 1.47589080 |
28 | HCK | 1.46544219 |
29 | IRAK3 | 1.45027883 |
30 | GRK7 | 1.40136300 |
31 | PIM1 | 1.37995836 |
32 | CSF1R | 1.37711262 |
33 | NUAK1 | 1.36897485 |
34 | EPHB1 | 1.36592558 |
35 | FGFR3 | 1.36489899 |
36 | MAP2K3 | 1.30492567 |
37 | MAP3K12 | 1.28265302 |
38 | IRAK1 | 1.28013810 |
39 | CLK1 | 1.21242681 |
40 | TRPM7 | 1.17142995 |
41 | IKBKB | 1.15382764 |
42 | ADRBK2 | 1.14283694 |
43 | MARK3 | 1.12504797 |
44 | TNK2 | 1.09201920 |
45 | RIPK1 | 1.08111478 |
46 | KSR2 | 1.04687581 |
47 | LYN | 1.01504251 |
48 | MAP3K1 | 1.01391634 |
49 | FGFR4 | 1.00191510 |
50 | RPS6KA4 | 0.98476800 |
51 | MAP3K6 | 0.96891057 |
52 | EEF2K | 0.94482157 |
53 | LRRK2 | 0.93981124 |
54 | MAP2K2 | 0.93556464 |
55 | PTK2B | 0.91251281 |
56 | SIK2 | 0.90988812 |
57 | PRKCQ | 0.90858629 |
58 | PIK3CG | 0.87799164 |
59 | BMPR2 | 0.86438409 |
60 | TTN | 0.85124040 |
61 | MAP2K6 | 0.81701907 |
62 | STK24 | 0.81105913 |
63 | NLK | 0.78790115 |
64 | SIK3 | 0.78624825 |
65 | PRKCH | 0.77460659 |
66 | MAP3K13 | 0.77090374 |
67 | CHUK | 0.75764983 |
68 | PRKD2 | 0.72354773 |
69 | MAP3K2 | 0.72193152 |
70 | JAK2 | 0.71451707 |
71 | NEK2 | 0.70402415 |
72 | CDK9 | 0.68798863 |
73 | MARK2 | 0.68786443 |
74 | MST4 | 0.67913698 |
75 | CDK4 | 0.67599913 |
76 | MAPK7 | 0.67215886 |
77 | STK4 | 0.66990918 |
78 | PTK6 | 0.66972771 |
79 | RIPK4 | 0.64966211 |
80 | MAP3K5 | 0.63155664 |
81 | FYN | 0.61840572 |
82 | BRSK2 | 0.60349580 |
83 | ACVR1B | 0.59650545 |
84 | PRKG2 | 0.59572680 |
85 | PKN2 | 0.58146332 |
86 | DMPK | 0.57998609 |
87 | IRAK2 | 0.57814401 |
88 | NEK9 | 0.56477693 |
89 | RET | 0.55268371 |
90 | SGK3 | 0.54922237 |
91 | CAMKK2 | 0.54762789 |
92 | KDR | 0.53488637 |
93 | EPHA3 | 0.53416060 |
94 | MAPK12 | 0.53121910 |
95 | MAP3K10 | 0.50262585 |
96 | PDPK1 | 0.49421965 |
97 | NME2 | 0.48101297 |
98 | GRK5 | 0.47926421 |
99 | STK11 | 0.47803203 |
100 | CDC42BPA | 0.44745901 |
101 | SGK2 | 0.44374279 |
102 | MAPKAPK2 | 0.43614989 |
103 | ALK | 0.43170768 |
104 | MAP3K3 | 0.42901755 |
105 | FGR | 0.42445297 |
106 | MAP2K4 | 0.42442002 |
107 | TGFBR1 | 0.41259696 |
108 | MELK | 0.41238404 |
109 | CDK12 | 0.41022173 |
110 | TRIB3 | 0.40830433 |
111 | MAPK4 | 0.40731203 |
112 | RAF1 | 0.40578638 |
113 | STK38 | 0.39856028 |
114 | ATR | 0.38638382 |
115 | KSR1 | 0.38197016 |
116 | MAP3K7 | 0.38169967 |
117 | EIF2AK2 | 0.38022458 |
118 | DYRK1B | 0.36621421 |
119 | MKNK2 | 0.36397370 |
120 | CDK6 | 0.35833434 |
121 | MAP3K11 | 0.34977373 |
122 | RPS6KC1 | 0.34973962 |
123 | RPS6KL1 | 0.34973962 |
124 | PIM2 | 0.34509266 |
125 | RPS6KA6 | 0.34475304 |
126 | HIPK2 | 0.33888604 |
127 | IGF1R | 0.33427163 |
128 | TAOK1 | 0.32065873 |
129 | PDK1 | 0.31870518 |
130 | TESK2 | 0.31842659 |
131 | MAPK11 | 0.31182711 |
132 | WNK1 | 0.29656112 |
133 | PASK | 0.29409875 |
134 | CAMKK1 | 0.29281243 |
135 | TAOK2 | 0.29211459 |
136 | PDGFRB | 0.28072761 |
137 | CDK8 | 0.27763164 |
138 | YES1 | 0.26385109 |
139 | PRKCD | 0.26076155 |
140 | DAPK2 | 0.24726296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.71396973 |
2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.44489712 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.21548999 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.11994865 |
5 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.96586094 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68689705 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39696621 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.36425112 |
9 | Measles_Homo sapiens_hsa05162 | 2.31789121 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.19377040 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.17570631 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.14236416 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95560339 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95076233 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91202723 |
16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78505774 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74198959 |
18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73611737 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72026454 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65925721 |
21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60959557 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60430779 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50205134 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49723901 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49498696 |
26 | Malaria_Homo sapiens_hsa05144 | 1.48076250 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43308782 |
28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39941427 |
29 | Shigellosis_Homo sapiens_hsa05131 | 1.38671064 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37831046 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37710154 |
32 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30894908 |
33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28773725 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.25664176 |
35 | Asthma_Homo sapiens_hsa05310 | 1.23817336 |
36 | Legionellosis_Homo sapiens_hsa05134 | 1.22677668 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.22144983 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.20716414 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20658241 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.10683928 |
41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08329001 |
42 | Tuberculosis_Homo sapiens_hsa05152 | 1.07456455 |
43 | Platelet activation_Homo sapiens_hsa04611 | 1.05599084 |
44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01835359 |
45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98725973 |
46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91030768 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89928680 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88671422 |
49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88506613 |
50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87992201 |
51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86582996 |
52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86237644 |
53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80698600 |
54 | DNA replication_Homo sapiens_hsa03030 | 0.80349873 |
55 | Salmonella infection_Homo sapiens_hsa05132 | 0.80255299 |
56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73986398 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 0.73773916 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73125843 |
59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70389717 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69083995 |
61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67971989 |
62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67359784 |
63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67261486 |
64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65802295 |
65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64314898 |
66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64204893 |
67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63494552 |
68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62613032 |
69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60599912 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60453842 |
71 | Base excision repair_Homo sapiens_hsa03410 | 0.60438620 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59973289 |
73 | Mismatch repair_Homo sapiens_hsa03430 | 0.58939293 |
74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58073384 |
75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57915537 |
76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57654519 |
77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56420430 |
78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56263547 |
79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54187446 |
80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54002687 |
81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53854755 |
82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52643900 |
83 | Homologous recombination_Homo sapiens_hsa03440 | 0.50481639 |
84 | Cell cycle_Homo sapiens_hsa04110 | 0.49988572 |
85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49812611 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48778776 |
87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47546677 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47176584 |
89 | RNA degradation_Homo sapiens_hsa03018 | 0.45103432 |
90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44813548 |
91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44779418 |
92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39806189 |
93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39254126 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38650161 |
95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38207752 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.37240287 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35336292 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34208905 |
99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33693145 |
100 | Phagosome_Homo sapiens_hsa04145 | 0.31570997 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30859093 |
102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29692071 |
103 | Focal adhesion_Homo sapiens_hsa04510 | 0.29167476 |
104 | Prostate cancer_Homo sapiens_hsa05215 | 0.28769807 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.28560072 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27904559 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27492079 |
108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27374453 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26467497 |
110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25714376 |
111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25657120 |
112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25501494 |
113 | Amoebiasis_Homo sapiens_hsa05146 | 0.24824123 |
114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24371356 |
115 | Spliceosome_Homo sapiens_hsa03040 | 0.24122321 |
116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22441551 |
117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20892579 |
118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20072259 |
119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.19391022 |
120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19182955 |
121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19070505 |
122 | Ribosome_Homo sapiens_hsa03010 | 0.17559196 |